Skip to main content
Press release September 25, 2026

Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva

Incyte Corp (INCY)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site